Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

24.92
Delayed Data
As of Jun 28
 +1.46 / +6.22%
Today’s Change
20.07
Today|||52-Week Range
42.48
-11.91%
Year-to-Date
Brexit Bargains Beckon the Brave
Jun 26 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close23.46
Today’s open23.86
Day’s range23.64 - 24.96
Volume485,410
Average volume (3 months)317,611
Market cap$789.2M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+67.86%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio104.1
Price/Sales11.37
Price/Book6.30

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S+0.96+5.72%
MGNXMacroGenics Inc+2.81+12.19%
SRPTSarepta Therapeutics...+0.86+5.07%
INSYINSYS Therapeutics I...+0.82+7.16%
Data as of 06/28/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs